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Abstract 
Background: Cancer results from the accumulation of mutations leading to the acquisition of cancer promoting 
characteristics such as increased proliferation and resistance to cell death. In colorectal cancer, an early mutation lead‑
ing to such features usually occurs in the APC or CTNNB1 genes, thereby activating Wnt signalling. However, substan‑
tial phenotypic differences between cancers originating within the same organ, such as molecular subtypes, are not 
fully reflected by differences in mutations. Indeed, the phenotype seems to result from a complex interplay between 
the cell‑intrinsic features and the acquired mutations, which is difficult to disentangle when established tumours are 
studied.
Methods: We use a 3D in vitro organoid model to study the early phase of colorectal cancer development. From 
three different murine intestinal locations we grow organoids. These are transformed to resemble adenomas after Wnt 
activation through lentiviral transduction with a stable form of β‑Catenin. The gene expression before and after Wnt 
activation is compared within each intestinal origin and across the three locations using RNA sequencing. To validate 
and generalize our findings, we use gene expression data from patients.
Results: In reaction to Wnt activation we observe downregulation of location specific genes and differentiation 
markers. A similar effect is seen in patient data, where genes with significant differential expression between the 
normal left and right colon are downregulated in the cancer samples. Furthermore, the signature of Wnt target genes 
differs between the three intestinal locations in the organoids. The location specific Wnt signatures are dominated 
by genes which have been lowly expressed in the tissue of origin, and are the targets of transcription factors that are 
activated following enhanced Wnt signalling.
Conclusion: We observed that the region‑specific cell identity has a substantial effect on the reaction to Wnt activa‑
tion in a simple intestinal adenoma model. These findings provide a way forward in resolving the distinct biology 
between left‑ and right‑sided human colon cancers with potential clinical relevance.
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Background
Activation of Wnt signalling is seen in a variety of 
malignancies [1, 2], and is particularly crucial in colon 
cancer [3]. Besides its role in cancer, Wnt signalling is 
tightly regulated in embryonal development and tissue 
homeostasis [4–6]. Activation of the Wnt pathway leads 
to an increase in proliferation rate and is sufficient to 
initiate intestinal adenoma formation [7]. Mutations in 
key components of the Wnt pathway are found in > 90% 
of colon cancer [8]. In wild type cells, Wnt family pro-
tein members (e.g. Wnt-2b, Wnt-3) serve as ligands to 
activate Wnt signalling [9]. Eventually the transcription 
cofactor β-Catenin (encoded by CTNNB1) promotes 
Wnt target gene expression via the transcription factor 
family TCF [10, 11]. Principal target genes include for 
example the oncogene c-Myc and the cell cycle regu-
lator Cyclin D1 [8, 12]. In absence of Wnt ligands, the 
β-Catenin destruction complex, comprising of APC, 
Axin and GSK3β, phosphorylates β-Catenin to initiate 
ubiquitin-dependent degradation [13, 14]. Stabiliza-
tion of β-Catenin can be achieved directly by mutation 
of phosphorylation sites in β-Catenin [15] or indirectly 
by inactivation of the destruction complex (mostly 
through APC inactivating mutations). Both mecha-
nisms are found to increase Wnt signalling in early car-
cinogenesis in the intestine.
It has been shown that the mutational profile is not 
sufficiently explaining heterogeneity between tumours 
[16]. It is speculated that the cell of origin, i.e. the nor-
mal cell that acquires the first cancer-promoting muta-
tion, might have a profound impact as well [17]. For 
example, in hematopoietic stem cells it was even shown 
that the same mutation can give rise to different pheno-
types, creating two subsets of stem cells with opposing 
behaviour resulting from the same genetic event [18]. 
In medulloblastoma, two molecular subtypes caused 
by different oncogenic pathways could be explained by 
distinct cells of origin [19]. However, it remains largely 
undefined to what extent the cell of origin determines 
the resulting tumour in the intestine. We propose that 
the longitudinal or craniocaudal axis in the intestine 
is an attractive model to study how the characteristics 
of cancer initiating cells influence the transformation 
process, using the confined variation of regional differ-
entiation in the same organ. Indeed, organoid cultures 
established from different regions of the murine intes-
tine were shown to conserve a location specific phe-
notype [20]. In addition, important earlier work form 
Leedham et  al. revealed that there exists a gradient of 
Wnt activity along the longitudinal axis in both mice 
and humans, translating into distinct stem cell dynam-
ics as distinct Wnt activating mutations along the intes-
tinal tract [21]. However, how exactly the cell of origin 
and the acquired mutations shape the gene expression 
profile and phenotype of the resulting pre-malignant 
clones remains elusive. Dissecting the interplay of the 
cancer initiating cells and oncogenic mutations in the 
gut is of potential great relevance as in colon cancer the 
location of the tumour has direct clinical implications.
In colon cancer the origin in the left or the right colon 
has an impact on the prognosis, right-sided being asso-
ciated with a worse prognosis [22]. Right-sided tumours 
tend to be more advanced, larger and more frequently 
poorly differentiated [23, 24]. This is not only a result of 
more advanced stage at presentation of disease but the 
molecular subtypes and underlying pathophysiologi-
cal mechanisms also differ between the locations [16]. 
To identify the role of intestinal location, earlier stud-
ies looked at differential expression along the intesti-
nal craniocaudal axis. A gene expression comparison 
between left and right-sided colon cancer found PRAC1, 
HOX6C and HOX13B as most differentially expressed 
[25]. This raises the question to which extend regional 
differences in colon cancer can be the result of pre-
existing differences in the origin tissue. A study that did 
compare normal and tumour samples from caecum and 
sigmoid/rectosigmoid found that most genes regulated in 
tumours did not overlap with genes significantly different 
between the locations [26]. However, microsatellite sta-
tus was available for less than half of the tumours, thus 
a difference in the molecular pathophysiology between 
the locations could not be excluded. To study the effect 
of tumour location with the same underlying patho-
mechanism, in this case early Wnt activation by means of 
Apc inactivation, Reichling et al. compared early adeno-
mas from ApcMin/+ mice between small or large intesti-
nal locations and to matched normal tissue [27]. Only a 
limited number of genes and no known Wnt target genes 
were found differentially expressed in both locations. 
Further studies of adenoma formation in mice observed 
a caudal shift of the tumour location from small intestine 
towards colon after introducing an additional knockout 
of Smad3 in the ApcMin/+Smad3−/− mouse or a heterozy-
gous mutation of Cdx2 in the Apc+/Δ716Cdx2+/− mouse 
[28, 29]. These studies confirm that the cell of origin in 
concert with specific mutations shape the ability of the 
intestine to transform as well as the properties of the 
resulting neoplasm.
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In this study we set out to further unravel the interac-
tion of the cell of origin and the effect of an oncogenic 
mutation activating the Wnt pathway at three different 
intestinal locations. We took advantage of location spe-
cific organoid cultures to limit the influence of the micro-
environment and solely focus on the direct interplay of 
the cell of origin and oncogenic pathway activation. 
Since this model is largely based on regional differences 
in transcriptional profiles and does not reach single cell 
resolution to study cell state differentiation markers, our 
findings reflect intestinal region-specific cellular features. 
We found that Wnt pathway activation partially oblit-
erates the location specific gene expression pattern, but 
at the same time installs novel region-of-origin-specific 
transcriptomic features that cannot be inferred from the 
non-transformed counterparts. Human gene expression 
data confirmed these findings stressing the relevance of 
these insights also for colon cancer. This study highlights 
the complex interplay of regional cell type-specific fea-
tures and oncogenic pathway activation in the intestine, 
and it establishes important context specific effects of 
Wnt signalling during tumour initiation.
Results
Organoid model of intestinal transformation
In order to study the interplay between the transcrip-
tional profiles of cancer initiating cells and onco-
genic pathway activation, we employed an in  vitro 
model for intestinal transformation (Fig.  1a). Intesti-
nal epithelial organoid cultures were established from 
three distinct regions of the murine intestine: proxi-
mal small intestine (prSI), distal small intestine (diSI), 
and colon. Subsequently, the organoids were trans-
duced with an oncogenic variant of Ctnnb1 (mutated 
to p.S33A;S37A;T41A;S45A, hereafter referred to as 
Ctnnb1S). The resulting stabilized β-Catenin protein is 
not effectively targeted for degradation, accumulates and 
translocates to the nucleus in order to interact with TCF 
family members and drive expression of Wnt target genes 
[15]. Following overexpression of Ctnnb1S, prSI and diSI 
organoids display a cystic growth pattern, reminiscent of 
organoids in which the negative Wnt regulator Apc has 
been inactivated (Fig.  1a, Additional file  1A) [30, 31]. 
Colonic organoids always show this cystic growth pat-
tern [32]. To validate that CTNNB1 protein was present 
at increased but physiological levels after transduction, 
we compared the protein levels in all locations (Fig. 1b). 
We generated global transcriptomic RNA sequencing 
data from wild type (wt) organoids and Ctnnb1S trans-
duced organoids from all three locations. We verified 
based on the read counts of the mutation hotspot region 
that wild type Ctnnb1 was similarly expressed in wt and 
Ctnnb1S organoids, and the mutated Ctnnb1:c.97T > G;1
09T > G;121A > G;133T > G was only detectable following 
Ctnnb1S transduction (Fig.  1c). Using quantitative PCR, 
we confirmed increased levels of Ctnnb1S expression in 
the models as well as increased expression of the Wnt 
target genes Ascl2, Axin2 and c-Myc (Fig.  1d). Next, we 
evaluated the expression of genes previously identified 
as Wnt target genes relevant in colon cancer [32] in the 
RNA sequencing data (Fig. 1e, f ). This analysis revealed 
a general overexpression of Wnt target genes following 
Ctnnb1S expression as expected, although regional differ-
ences were detected. Moreover, we employed a gene set 
enrichment analysis (GSEA) to identify gene expression 
profiles that are significantly altered following Wnt sig-
nalling activation compared to the wt organoids (Fig. 1g). 
This established that c-Myc target gene signatures and 
gene signatures relating to the cell cycle and proliferation 
were more abundantly expressed just like the Wnt signal-
ling gene signature itself. In combination, our data reveal 
that this in vitro model system exhibits features reminis-
cent of intestinal transformation.
Oncogenic Wnt activation erases region of origin related 
cell identity
To investigate how active Wnt signalling modifies region-
specific gene expression profiles in intestinal epithelial 
cells, we identified internal sets of location marker genes. 
We plotted 15 genes (Fig.  2a) or 200 genes (Additional 
file 1B) that are significantly higher expressed in wt orga-
noids of each location as compared to the other intestinal 
(See figure on next page.)
Fig. 1 Model for Wnt activation. a Organoids were grown from 3 locations of the wild type (wt) murine intestine, and after transduction with 
stable Ctnnb1S (Cβ) a cystic morphology can be observed in all locations. b Immunoblot of CTNNB1 and loading control GAPDH in organoids 
grown without (wt) or with transduced  Ctnnb1S (Cβ). c Number of reads matching the wild type (wt.) hotspot region of Ctnnb1 and the mutated 
(mut.) hotspot region of Ctnnb1:c.97T > G;109T > G;121A > G;133T > G. d Quantitative PCR of Ctnnb1 and important Wnt target genes, n = 3, *p < 0.05, 
**p < 0.005 (Student’s t‑test), mean fold change in vertical number. All error bars represent S.E.M. e Expression of Wnt target genes [32] as average 
(n = 3) scaled count, centred around the location average. Right columns show summarized average logarithmic fold change (log2FC) of Cβ/wt 
and mean read count across locations. Indicated gene symbols are significantly differentially expressed in the average of all locations (adjusted 
p‑value < 0.05, Wald ‑Test). f Gene Set Enrichment Analysis of Wnt target genes [32] in each location separately using GSEA preranked mode or (g) 
testing enrichment of Hallmark gene sets [50] across all locations using EGSEA
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regions. Almost uniformly, these genes were downregu-
lated following Wnt pathway activation, indicating that 
oncogenic Wnt pathway activation erases part of the 
location specific cell identity (Additional file  2 lists fold 
changes). This was also confirmed by GSEA for gene sets 
encompassing the 200 most significant location specific 
genes (Fig.  2b), demonstrating for all locations a down-
regulation of gene sets that represent location defined cell 
identity. We detected the same trend when we used exter-
nal location signatures which were previously reported 
(Fig. 2a) [20, 33], or when we employed an in vivo derived 
set of genes which were found to be specifically enriched 
in the intestine by the Human Protein Atlas (Fig.  2a) 
[34–37]. Since Wnt signalling is known to be an impor-
tant driver of differentiation during embryogenesis, but 
maintains stemness in adult intestines, we were curious 
how our findings relate to the level of cell type specificity. 
We observed that genes marking differentiated cells, as 
described for specific cell types in single cell gene expres-
sion studies [38–40], were significantly downregulated 
in Ctnnb1S expressing organoids (Fig.  2a, c). From each 
region we selected two location specific genes based on 
the highest significance and fold change to validate with 
quantitative PCR that the expression decreased after Wnt 
activation (Additional file  1C). We confirmed the loca-
tion specificity and loss after transformation on protein 
level for the growth factor Regenerating islet-derived 1, 
REG1, the ileal Fatty acid binding protein 6, FABP6, and 
the mucin protein Mucin-1, MUC1 (Additional file 1D). 
Taken together, these analyses indicate that oncogenic 
Wnt activation reduces expression of genes that are char-
acteristic for the specific cellular identity associated with 
the intestinal location.
In order to evaluate if this phenomenon can also be 
captured in human cancers we established location spe-
cific profiles using the The Cancer Genome Atlas (TCGA) 
dataset. Because small intestinal cancer is very rare and 
left versus right colon cancers represent clinically rel-
evant distinct entities we focus on this distinction. We 
selected samples from the normal colon and defined 
genes with the most significant differential expression 
between the right colon (caecum and ascending colon) 
and the left colon (descending colon and sigmoid). Inter-
estingly, among the significant side-specific genes from 
the human normal colon, we found a significant cor-
relation with the location specific genes from our com-
parison of murine colon vs. small intestine organoids, 
suggesting that our model reflects a general proximal vs. 
distal effect (Additional file 1E). Next, we selected colon 
adenocarcinoma samples that harbour Wnt pathway 
activating mutations in the APC gene. We included only 
cancer samples from microsatellite stable (MSS) cancers, 
since microsatellite instable cancers are a clearly distinct 
entity characterized by distinct pathogenesis [41–43]. 
The most important clinical features are summarized in 
Additional file 3A. In line with our in vitro findings using 
murine organoids, also in these patients’ cancer samples, 
the location specific gene expression profile is signifi-
cantly impaired confirming that Wnt pathway activation 
obliterates location specific gene expression patterns 
(Fig. 3a, b, Additional file 3B). In left-sided colon cancers, 
the consensus molecular subtype (CMS) 2 is overrepre-
sented and thus the Myc pathway is more activated than 
in right-sided colon cancers (Additional file 4B). We pre-
viously established that activation of the Wnt pathway is 
more prominent in CMS2 than in other CMSs [16]. This 
might explain why the downregulation of location mark-
ers is more pronounced in left-sided cancer samples. 
To identify transcription factors that could be involved 
in the regulation of the genes differentially expressed 
between left and right colon, we tested which transcrip-
tion factor target gene sets were overlapping. We identi-
fied the target gene sets of CDX2, CDX1, ISX, CREB3L3 
and GATA5, all reported as linked to differentiation in 
intestinal cells with differences along the intestinal axis 
[44–48] (Fig. 3c). Of note, the genes encoding these tran-
scription factors were themselves not significantly dif-
ferentially expressed between left and right normal colon 
(Additional file 3C), indicating another activation mech-
anism. However, in a subset we found the transcription 
factor expression downregulated in colon cancer, corre-
lating with a decreasing overlap of their targets (Fig. 3d). 
To test which genes were building the location marker 
sets in normal tissue in  vivo, we performed a GSEA on 
Fig. 2 Location signatures are downregulated upon Wnt activation. a Heatmap shows average (n = 3) scaled counts for both conditions of 
each location, additional columns show summarized mean log2FC(Cβ/wt) and mean read count across locations. Genes marked with asterix are 
significantly differentially expressed in the average of all locations (adjusted p‑value < 0.05, Wald‑Test). Internal location (int. loc.) marker genes 
are genes which showed the most significant (Wald‑Test) upregulation in the wt samples of prSI, diSI or colon compared to all other locations’ wt 
samples, respectively. External location (ext. loc.) marker genes were previously reported to be specific to intestinal divisions [20, 33] or specifically 
enriched in the intestine based on the Human Protein Atlas [34–37]. Cell type marker genes were previously reported to be specific to differentiated 
intestinal cells [38–40]. b Our own location signature exhibited a significant downregulation upon Wnt activation in each location separately 
using Gene Set Enrichment Analysis GSEA preranked mode. c Cell type marker genes [38–40] also showed significant downregulation upon Wnt 
activation in Gene Set Enrichment Analysis using GSEA preranked mode
(See figure on next page.)
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50 curated Hallmark gene sets from the Molecular Sig-
nature Database [49–51] and found that gene sets asso-
ciated with inflammatory response tended to be higher 
in the right colon (Fig.  3e). It is interesting to note that 
immune activated microsatellite instable tumours, 





Fig. 3 Location specific signature partially erased in human colon cancer. a With transcriptome data from TCGA [8] we identified genes with 
the most significant upregulation in left colon versus right colon (log2FC > 1, adjusted p‑values < 0.01, Wald‑Test) in the normal tissue samples 
(left panel). The expression of those genes in MSS APC mutated colon cancer samples of the left colon is shown in the right panel. b The colon 
side‑specific signatures were analysed individually using GSEA. c Genes differentially expressed between left and right TCGA normal colon tissue 
samples were tested for overlap with transcription factor target gene sets using ChEA3 mean ranks with interaction [79]. Resulting ChEA3 scores 
were compared to their expression in normal and colon cancer samples and in CREB3L3 and ISX we found a high Pearson‑correlation, indicated in 
brackets (d). Genes differentially expressed between left and right TCGA normal colon tissue samples were tested for enrichment in Hallmark genes 
sets [50] using EGSEA (e)
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predominantly located in the right colon. The fact that 
inflammatory response pathways (interferon α, inter-
feron γ, allograft rejection) were already significantly 
enriched in the right normal colon, suggests an inher-
ent location specific mechanism influencing the immune 
microenvironment.
Oncogenic Wnt activation uncovers a region of origin 
specific expression pattern
Importantly, in addition to maintaining expression of 
genes characteristic of cell identity during transforma-
tion, the region of origin can also impact on the tran-
scriptomic profiles of cancers in a different fashion. It is 
perceivable that activation of the Wnt pathway results in 
activation of genes in a location specific fashion, thereby 
installing a novel location specific identity. To test this 
hypothesis, we identified the Wnt target genes for each 
location separately, by comparing the expression pro-
files of the wt organoids of the different regions with the 
respective Ctnnb1S counterparts (Fig.  4a). This analy-
sis revealed that following Wnt activation the organoids 
from different regions respond by activating partially 
distinct sets of Wnt target genes. For a substantial set of 
genes even an inverse relationship was detected, i.e. acti-
vation upon Wnt signalling in one location and down-
regulation in Ctnnb1S organoids from another location. 
This suggests that Wnt activation installs an otherwise 
undetected location specific gene expression program. 
We were interested in detailing the nature of the genes 
that were activated in a region of origin specific fashion. 
With GSEA we found that the upregulated Wnt target 
genes tended to be lowly expressed before Wnt activa-
tion (Fig. 4b). To test statistically, which genes responded 
to Wnt activation differently between the locations, we 
applied a likelihood ratio test for the effect of the Wnt 
activation depending on the location. The resulting genes 
were assigned to the three locations based on where they 
showed the maximum (positive) log2 fold change (Addi-
tional file  4A). To identify transcription factors which 
could explain the regional differences, the upregulated 
Wnt target genes of each location were tested for over-
lap with transcription factor target gene sets. We found 
that the expression levels of the transcription factors with 
high evidence for overlapping target genes were rather 
low in wild type and showed upregulation upon Wnt 
activation (Fig. 4c). To examine, whether Wnt signatures 
differ also between human colon cancer samples from 
different locations, we compared again MSS tumours 
with a mutation in APC from TCGA data. Among the 
Wnt target genes which show a trend to differential 
expression between left- and right-sided colon cancer, we 
found most genes to be upregulated more in left-sided 
cancer samples, however a few genes were more acti-
vated in the right-sided colon cancer samples (Additional 
file  4C). This is in line with previous reports that Wnt 
activation is higher in distal colon cancer [52, 53]. It also 
gives the indication that Wnt response is qualitatively 
location dependent even in patients samples.
Discussion
In this study we set out to disentangle the impact of 
the cell that transforms, and the effects of the pathway 
that drives carcinogenesis on the resulting gene expres-
sion profile. For this fundamental research question, 
we employed a model system with low complexity in 
order to reduce the confounding factors. The organoid 
model allowed us to study the epithelial component of 
early carcinogenesis through titrated Wnt activation. 
To achieve this, we transduced the stabilized version 
of Ctnnb1 downstream of APC, because Apc requires 
biallelic mutations for cancer initiating Wnt activation 
which seem to (inter)depend on the intestinal location 
[54]. With organoids from three different murine intes-
tinal locations we defined regional identity markers 
using RNA sequencing data, extending earlier studies of 
others [20]. These location identity markers were con-
cealed after Wnt activation via Ctnnb1S as compared to 
the original wild type organoids. As expected, cell type 
differentiation markers were downregulated [55]. The 
upregulated Wnt target genes differed between the loca-
tions and were generally lowly expressed in the control 
organoids. It was previously reported that the intestinal 
axis from proximal to distal needs an increasing dose of 
added Wnt signal to exceed the polyp initiation threshold 
Fig. 4 Wnt response is partly location specific. a Genes upregulated after Wnt activation (fold change > 1.2, adjusted p‑value < 0.05, Wald‑Test) were 
identified in each region separately. Genes which appeared significantly upregulated in all locations individually are shown on top, followed by 
remaining 20 most significantly upregulated genes for each location (intersecting genes shown in between). Heatmap shows average (n = 3) scaled 
counts per condition, centred around the location average, right columns show summarized log2FC(Cβ/wt) and mean read count across locations. 
Genes marked with asterix are differentially expressed in the average of all locations (adjusted p‑value < 0.05, Wald‑Test). b Gene Set Enrichment 
Analysis of genes upregulated after Wnt activation (fold change > 2, 200 lowest adjusted p‑values < 0.05, Wald‑Test) in each location using GSEA 
preranked mode, after genes were ranked based on expression in each location’s expression in wt vs. other locations expression in wt. c The genes 
upregulated after Wnt activation from each location were examined for overlap with transcription factor target genes using ChEA3, the resulting 
score was tested for correlation with the expression of the corresponding transcription factor coding gene in each location
(See figure on next page.)
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[21], which was in our model reflected by an increasing 
amount of mutated Ctnnb1S. The lower levels of Ctnnb1S 
in prSI might explain why results were less pronounced, 
yet significant, in this location. To validate the impor-
tance of our findings for the disease we were modelling, 
we examined human normal colon and colon carcinoma 
a b
c
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data from distinct colon regions. Because variation 
between left and right sided colon cancer is tightly con-
nected to differences in pathomechanisms (reviewed in 
[22]), we narrowed down the problem by focussing on 
MSS Wnt activated colon cancer samples to unveil the 
role of region-specific transcriptional background. When 
we compared normal and cancer samples from the left 
and right colon, we could recapitulate both of our main 
observations from the murine organoid model: conceal-
ing of location markers and location differences in known 
Wnt target genes.
Our analyses reveal that there is a profound impact of 
the region-specific cellular features on the transcriptomic 
profiles of the resulting tumours, at least along the dif-
ferent locations of the intestinal tract. However, unlike 
previously assumed, cells do not directly carry over their 
cell specific gene expression profiles, but reveal initially 
hidden region-specific signatures. This has implications 
for the concept of the cell of origin in cancer as well as 
for the methods used to study this phenomenon. Our 
data suggest that cell or tissue specific profiles from non-
transformed tissues are non-informative to predict the 
region of origin of a given cancer. Our results indicate 
that the region-specific features of cells can be partially 
erased, while the region of origin does have an important 
impact on defining which genes are activated upon onco-
genic pathway activity.
Several limitations of this study include the fact that we 
have only evaluated the effect of a Wnt activating muta-
tion in specific regions of the intestine. It remains to be 
defined if our results can be generalized to other onco-
genic pathways and organs. For example, KRAS muta-
tions are more prevalent in the proximal colon and it has 
been recently suggested that certain KRAS mutations 
might be location dependent [56, 57]. Moreover, RAS 
mutations have a synergistic effect with APC mutations 
[58] so that the further examination of location depend-
encies in other oncogenic pathways should incorporate 
potential cooperative effects. Another limitation is that 
we only studied the impact of the region of origin on the 
longitudinal axis in the intestine. It remains unclear how 
the profiles of distinct cell types along the differentiation 
axis in the intestine, e.g.  Lgr5+ stem cells, absorptive pro-
genitors or neuroendocrine cells, shape the phenotype of 
the resulting neoplasm. This is an important unresolved 
question, in particular because an increasing range of 
cell types is identified as amendable to transformation, 
usually as a result of inflammation associated signals 
from the environment [59, 60]. It remains an attractive 
explanation for the notion that the highly diverse phe-
notypes of colon cancers can only partially be explained 
by genetic differences. On the other hand, the cell type 
specific differentiation gradient is already known to be 
convertible, involving major changes in chromatin acces-
sibility but maintaining a widely stable epigenetic status 
[61–63]. In that way, it seems less likely that differentia-
tion-related features are hardwired and conserved in can-
cers of the intestine.
To conclude, at a very basic level, our results provide 
further support to the fact that distinct regions in the gut 
present with distinct features. Some of these are poten-
tially clinically significant. For example, tumour location 
in the colon is associated with response to anti-EGFR 
agents in the RAS/RAF wild type population. Whilst left-
sided cancers display marked clinical benefit, right-sided 
tumours are less responsive [64, 65]. These observations 
might be associated with regional differences that are 
exposed following oncogenic pathway activation. Hence, 
our findings provide a way forward in an attempt to 
resolve this notion.
Conclusion
We observed that region-related cellular identity has a 
substantial effect on the reaction to Wnt activation in a 
simple intestinal adenoma model. While the tissue spe-
cific pattern is partially erased, the response to onco-
genic transformation cannot be inferred from the tissue 
of origin. These findings highlight the context dependent 
effect of oncogenic Wnt signalling and provide a way for-
ward in resolving the distinct biology between left- and 




Isolation of small intestine (SI) and colon crypts from 
wild type mice was adapted from Sato et al. [66]. Briefly, 
resected prSI, diSI and colon were opened longitudi-
nally, villi were removed and cut into 0.5  mm pieces. 
The fragments were washed several times with cold PBS. 
After this, the intestinal pieces were incubated in 2 mM 
(SI) or 25 mM (colon) EDTA in PBS at 4  °C for 30 min, 
in order to detach intestinal crypts from the basal layer. 
After removal of EDTA, crypts were resuspended in 
10  mL of cold PBS 10% FCS, pipetted up and down 
vigorously, and passed through a 70  μm strainer. Sub-
sequently, crypts were resuspended in Matrigel® (Corn-
ing), seeded in 24-well plates, and supplemented with 
Advanced DMEM/F12 medium (Gibco) containing 1× 
N2 (Gibco), 1× B27 (Gibco) 50  ng/mL, 10  mM HEPES 
(Boehringer), Glutamax (Gibco) and 1  mM N-acetyl-
cysteine (Sigma-Aldrich), supplemented with 50  ng/mL 
murine EGF (TEBU-Bio) and 10% of Noggin and R-spon-
din1 conditioned media (hereafter called ENR medium). 
In addition, 10 μM CHIR (Axon Medchem) and 10 μM 
Rock inhibitor (Sigma-Aldrich) were added to all crypt 
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cultures. After two days in culture, CHIR was removed 
from SI crypt cultures and Rock inhibitor from both, SI 
and colon. Cultures were incubated at 37 °C and 5%  CO2.
Generation of  Ctnnb1S construct
A stabilized (mutated to p.S33A;S37A;T41A;S45A) ver-
sion of Ctnnb1 (GenBank ID: NM_001165902.1:c.[97T > 
G;109T > G;121A > G;13T > G]) was obtained in pLX304 
as a gift from William Hahn (Addgene # 42561) and 
cloned into the vector pWPXL downstream the consti-
tutively active promotor EF1α (Addgene #12,257) which 
was kindly provided by Didier Trono Finally, P2A-dsRed 
sequence was cloned downstream Ctnnb1S gene. All 
restriction enzymes were from New England Biolab. Len-
tiviral particles were generated using PEI transfection 
with 2nd generation packaging plasmids VSV-G pMD2.G 
(Addgene #12259) and PAX2 (Addgene #12260), kindly 
provided by Didier Trono respectively.
Generation of adenoma organoids
Wild type organoids from prSI, diSI and colon were 
transduced with the pWPXL-Ctnnb1S-P2A-dsRed plas-
mid in order to generate adenoma organoids [67, 68]. 
Once adenoma cultures were established, selection for 
positively transduced organoids was performed. Since 
the Wnt pathway is upregulated in these organoids, 
the dependence on external Wnt agonist is diminished. 
Therefore, after four days selection for pWPXL-Ctnnb1S-
P2A-dsRed positive organoids was performed by cultur-
ing them in selection medium, ENR without R-spondin1 
conditioned medium for SI and ENR for colon organoids. 
Visual expression of the dsRed construct by fluorescence 
microscopy (Zeiss AxioVert 200) confirmed successful 
transduction (Additional file 1A). We further confirmed 
Ctnnb1 upregulation in quantitative PCR, Western Blot 
and on RNA sequencing data.
Quantitative PCR
Overexpression of Ctnnb1, detection of Wnt targets 
and specific region markers were validated by quantita-
tive PCR. In short, RNA was isolated using NucleoSpin® 
RNA kit (Macherey–Nagel). Then, 500  ng of total RNA 
were retrotranscribed using 5 μg/mL polydT primers and 
SuperScript® III reverse transcriptase (Thermo Scien-
tific) at 50  °C. cDNA was diluted 1:20 in distilled water 
and amplified in 5 μL reactions with LightCycler® 480 
SYBR Green I Master 2X on a LightCycler® 480 (Roche). 
Results were analysed using LightCycler® 480 software 
version 1.5.1.62. Relative fold gene expression was cal-
culated using the delta-delta Ct  (2−DDCt) method [69]. 
Primer sequences can be found in Additional file 5.
Western blotting
Organoid protein lysates were made using Cell Lysis 
Buffer (Cell Signaling Technologies) according to manu-
facturers’ protocol. Subsequently, protein concentra-
tions were determined using  Pierce™ Protein Assay Kit 
(Thermo Scientific). Next, 30  μg protein was loaded in 
4–15% Mini-PROTEAN® TGX precast protein gels (Bio-
Rad), separated by electrophoresis and transferred to 
PDVF membranes using the Trans-Blot Turbo System 
(Bio-Rad). Membranes were blocked in 5% Skim Milk 
Powder (Sigma) and primary antibodies were incubated 
overnight in 5% BSA/TBST and washed with TBST (0.1% 
Tween® 20, P1379, Sigma). HRP-conjugated secondary 
antibodies were incubated for 1  h at room temperature 
in 5% BSA/TBST and washed with TBST. Protein lev-
els were detected using  Pierce™ ECL Western Blotting 
Substrate (Thermo Scientific) and revealed using Image-
Quant LAS 4000 (GE Healthcare Life Sciences). Primary 
antibodies used are anti-β-Catenin (9562, Cell Signaling 
Technologies), anti-REG1A (PA5-70,626, Thermo Sci-
entific), anti-FABP6 (PA5-50,407, Thermo Scientific), 
anti-MUC1 (PA5-95,487, Thermo Scientific) and anti-
GAPDH (MAB374, Millipore). Secondary antibodies are 
anti-rabbit-HRP (7074, Cell Signaling technologies) and 
anti-mouse-HRP (1070–05, Southern Biotech). Images 
were cropped around the target protein sizes. Load-
ing control was performed with GAPDH staining for all 
membranes.
RNA sequencing
Total RNA was isolated using NucleoSpin RNA isola-
tion kit (BIOKÉ, Leiden, Netherlands) and the quality 
of RNA samples was subsequently assessed using Agi-
lent 2100 Bioanalyzer (Agilent Technologies Inc., Santa 
Clara, CA, USA). Generation of sequencing libraries was 
performed using the TruSeq RNA Library Preparation 
Kit v2 (Illumina, San Diego, CA, USA) and 1 μg of total 
RNA. Sequencing was performed on HiSeq2500 (Illu-
mina) with 50-bp single-end reads. Average sequencing 
depth (total number of reads) was 17.69 M reads (range 
11.28  M to 23.32  M). Mean coverage (number of reads 
× read length / target size) of all genes was on average 
4.395 (range 2.658 to 6.480). After excluding genes with a 
mean read count < 1 for downstream analysis, the average 
coverage across the samples was 11.293 (range 6.831 to 
16.654).
Data retrieval
Reads were aligned and quantified using HISAT2 (2.0.4), 
samtools (1.3.1) and subread featureCounts (1.5.0-
p1) with GRCm38.85 [70–72]. The mutated region of 
Ctnnb1S comprising four mutations was identified among 
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the unmapped reads as a 37b long string “GCTG GAA 
TCCAT GCTG GTG CCACC GCCA CAG CTCCT G” as 
opposed to the wild type “TCT GGA ATC CAT TCT GGT 
GCC ACC ACC ACA GCT CCT T” among the mapped 
reads.
TCGA gene expression data as raw counts and clini-
cal data was obtained using TCGAbiolinks (2.12.3) [73]. 
Only samples with an annotated tumour site or site of 
resection or biopsy were analysed, assigning sigmoid and 
descending colon to left colon and cecum and ascending 
colon to right colon. MSS tumours with a somatic APC 
mutation were selected based on the annotations of the 
original publication [8]. CMS labels were obtained from 
the original publication [16].
Data analysis
DESeq2 (1.10.1) was applied for normalization and dif-
ferential expression analysis [74]. The results were 
annotated with org.Mm.eg.db (3.8.2) or org.Hs.eg.db 
(3.8.2) and plotted using ComplexHeatmap (2.0.0) or 
ggplot2 (3.2.0) [75]. After ranking genes according to the 
decreasing Wald statistics value, GseaPreranked (v3.0) 
was used for gene set enrichment analysis on ENCODE 
transcription factor target gene sets, Wnt target genes 
and location markers from literature as well as gene 
lists generated from our own data using cut-offs of fold 
change > 1.2 and Benjamini–Hochberg adjusted p-value 
of 0.05 [20, 32, 33, 51, 74]. Results were replotted adapt-
ing Rtoolbox::replotGSEA (v.1.4). An alternative Gene 
Set Enrichment method based gene expression analysis 
with limma::voom(3.40.2) and edgeR (3.26.5) was used 
on MiSigDB Hallmark gene sets with EGSEA (1.12.0) [49, 
50, 76–78]. Overlapping transcription factor target gene 
sets were identified using ChEA3 mean rank mode on the 
200 genes with the highest significant upregulation (fold 
change > 2, adjusted p-value < 0.05) between  Ctnnb1S and 
wt in each location or between the left and right nor-
mal colon from TCGA samples [74, 79]. The score was 
inverted in order to be maximal with the highest overlap 
evidence. From genes coding these transcription factor 
we selected genes that showed variance in expression in 
wild type and in the log2 fold change upon Wnt activa-
tion between the locations (above average) and plot-
ted their correlation to the corresponding transcription 
factor targets overlap. Correlation was tested using the 
Spearman method in R package ggpubr (0.2.5).
Supplementary information
Supplementary information accompanies this paper at https ://doi.
org/10.1186/s1293 5‑020‑01661 ‑6.
Additional file 1. Validation of findings. (A) The expression of dsRed 
after  Ctnnb1S transduction was examined by fluorescence microscopy 
including images merged with bright field, scale bar = 200 μm. (B) Heat‑
map depicts average (n = 3) scaled counts for both conditions of each 
location, right columns show summarized log2 fold changes, log2FC(Cβ/
wt), and mean read count across locations. Genes represent our location 
signatures comprising each 200 most significantly (Wald‑Test) upregu‑
lated genes comparing the wt samples of prSI, diSI or colon to all other 
locations’ wt samples, respectively. (C) Validation of location marker genes 
with quantitative PCR, n = 3, Student’s t‑test, error bars represent S.E.M., 
mean fold change in vertical number. (D) Immunoblot of prSI location 
marker REG1, diSI location marker FABP6, colon location marker MUC1 and 
control GAPDH, protein lysates from organoids grown without (wt) or with 
transduced  Ctnnb1S (Cβ). The loading control is exemplarily shown for 
the FABP6 membrane. (E) For genes which are significantly differentially 
expressed in the murine organoid locations in colon vs. small intestine 
and in TCGA normal samples from the left vs. right colon we find a signifi‑
cant correlation (Spearman) of the log2 fold changes (log2FC).
Additional file 2. Location signatures are downregulated upon Wnt 
activation. Genes depicted in Fig. 2A are provided in a table format with 
compiled log2 fold changes (l2FC) (n = 3) for each location separately. The 
comparison of the wt samples of prSI, diSI or colon to all other locations’ 
wt samples retrieved the most significantly (Wald‑Test) upregulated genes 
categorized as internal location (int. loc.) marker genes. Corresponding 
log2 fold changes are listed under l2FC.loc for all locations. External loca‑
tion (ext. loc.) marker genes were previously reported to be specific to 
intestinal divisions [20, 33] or specifically enriched in the intestine based 
on the Human Protein Atlas [34–37]. Cell type marker genes were previ‑
ously reported to be specific to differentiated intestinal cells [38–40]. The 
downregulation of location and differentiation markers upon Wnt activa‑
tion can be appreciated in the separately calculated log2 fold changes 
(Cβ/wt) listed under l2FC.ctn.vs.wt. NA values correspond to expression 
below detection in either condition or a non‑mappable gene symbol 
from literature.
Additional file 3. Location signatures are downregulated upon Wnt 
activation in vivo. (A) To validate our findings in human in vivo samples 
we used TCGA data [8] with the summarized clinical characteristics of 
patients. *Transverse colon samples were depicted but not included in 
the differential expression analyses between the two sides, due to lack of 
more specific site information. The same holds for a single sample from 
normal transverse colon of a female patient (44 years). (B) Using tran‑
scriptome data from TCGA [8] we identified genes differentially expressed 
(adjusted p‑value < 0.01, Wald‑Test) between left and right colon in the 
normal tissue samples (left panel). The expression of those genes in MSS 
APC mutated colon adenocarcinoma samples is shown in the right panel. 
Samples for transverse colon are included for comparison purpose. (C) 
Transcription factors for which an enrichment of their target genes was 
observed in normal colon side‑specific genes show little or no differential 
expression of their own coding genes in the normal colon but partially a 
differential expression between normal colon and colon cancer samples.
Additional file 4. Wnt response is partly location specific. (A) Heatmap 
with average (n = 3) scaled counts, centred around the location mean. 
Right columns show summarized log2FC(Cβ/wt) and mean read count 
across locations. Using a likelihood ratio test, we identified genes, in which 
the reaction to Wnt activation depends significantly on the location. The 
location dependently upregulated genes were separated into 3 groups, 
where the upregulation was maximal in prSI, diSI or colon, respectively. (B) 
Genes differentially expressed between left and right TCGA colon cancer 
samples were tested for enrichment in Hallmark genes sets using EGSEA. 
(C) Using transcriptome data from TCGA [8] we tested, which Wnt target 
genes [32] were differentially expressed between left and right colon 
in the MSS APC mutated colon cancer samples. Wnt genes with a trend 
to differential expression between the colon cancer locations (adjusted 
p‑value < 0.05 at TP53RK, all genes p‑value < 0.15, Wald‑Test) are plotted 
(right panel). The expression of those genes in normal samples is shown 
in the left panel. Samples for transverse colon are included for comparison 
purpose.
Additional file 5. Primers used in quantitative PCR.
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Abbreviations
CMS: Consensus molecular subtype; diSI: Distal small intestine; GSEA: Gene set 
enrichment analysis; MSS: Microsatellite stable; prSI: Proximal small intes‑
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